APO Research
Talk to an analyst

APO RESEARCH · REPORT

Trauma Hemostasis Device

Compare research editions
View pricing & licenses

Selected research

Industry Research

Trauma Hemostasis Device Industry Research Report 2026

8 January 2026145 pages

Choose your research edition.

Industry ResearchTrauma Hemostasis Device Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Trauma Hemostasis Device Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Trauma Hemostasis Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Trauma Hemostasis Device Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Trauma Hemostasis Device Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Trauma Hemostasis Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Trauma Hemostasis Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Trauma Hemostasis Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Trauma Hemostasis Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Trauma Hemostasis Device include Medtronic, RevMedx, Organon, Stryker, Delfi Medical Innovations, TacMed Solutions, J&J, Baxter and BD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Trauma Hemostasis Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Trauma Hemostasis Device Market by Company

Medtronic

RevMedx

Organon

Stryker

Delfi Medical Innovations

TacMed Solutions

J&J

Baxter

BD

BBraun

Integra Life Sciences

AdvanceMedicalSolution

CSL Behring

Hairun Biotechnology

Zimmer Biomet

Pfizer

Smith & Nephew

Cohera Medical

Haohai Biotechnology

Sexsays

Trauma Hemostasis Device Segment by Type

Hemostatic Devices

Hemostatic Agents

Other

Trauma Hemostasis Device Segment by Application

Hospital

Clinic

Other

Trauma Hemostasis Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trauma Hemostasis Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Trauma Hemostasis Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trauma Hemostasis Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Trauma Hemostasis Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Trauma Hemostasis Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Trauma Hemostasis Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Trauma Hemostasis Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Trauma Hemostasis Device Sales (k units) of Manufacturers (2021-2026) Table 7. Global Trauma Hemostasis Device Sales Market Share by Manufacturers (2021-2026) Table 8. Global Trauma Hemostasis Device Revenue of Manufacturers (2021-2026) Table 9. Global Trauma Hemostasis Device Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Trauma Hemostasis Device Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Trauma Hemostasis Device Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Trauma Hemostasis Device, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Trauma Hemostasis Device, Product Type & Application Table 14. Global Trauma Hemostasis Device Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Trauma Hemostasis Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Medtronic Company Information Table 19. Medtronic Business Overview Table 20. Medtronic Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Medtronic Trauma Hemostasis Device Product Portfolio Table 22. Medtronic Recent Developments Table 23. RevMedx Company Information Table 24. RevMedx Business Overview Table 25. RevMedx Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. RevMedx Trauma Hemostasis Device Product Portfolio Table 27. RevMedx Recent Developments Table 28. Organon Company Information Table 29. Organon Business Overview Table 30. Organon Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Organon Trauma Hemostasis Device Product Portfolio Table 32. Organon Recent Developments Table 33. Stryker Company Information Table 34. Stryker Business Overview Table 35. Stryker Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Stryker Trauma Hemostasis Device Product Portfolio Table 37. Stryker Recent Developments Table 38. Delfi Medical Innovations Company Information Table 39. Delfi Medical Innovations Business Overview Table 40. Delfi Medical Innovations Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Delfi Medical Innovations Trauma Hemostasis Device Product Portfolio Table 42. Delfi Medical Innovations Recent Developments Table 43. TacMed Solutions Company Information Table 44. TacMed Solutions Business Overview Table 45. TacMed Solutions Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. TacMed Solutions Trauma Hemostasis Device Product Portfolio Table 47. TacMed Solutions Recent Developments Table 48. J&J Company Information Table 49. J&J Business Overview Table 50. J&J Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. J&J Trauma Hemostasis Device Product Portfolio Table 52. J&J Recent Developments Table 53. Baxter Company Information Table 54. Baxter Business Overview Table 55. Baxter Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Baxter Trauma Hemostasis Device Product Portfolio Table 57. Baxter Recent Developments Table 58. BD Company Information Table 59. BD Business Overview Table 60. BD Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. BD Trauma Hemostasis Device Product Portfolio Table 62. BD Recent Developments Table 63. BBraun Company Information Table 64. BBraun Business Overview Table 65. BBraun Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. BBraun Trauma Hemostasis Device Product Portfolio Table 67. BBraun Recent Developments Table 68. Integra Life Sciences Company Information Table 69. Integra Life Sciences Business Overview Table 70. Integra Life Sciences Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Integra Life Sciences Trauma Hemostasis Device Product Portfolio Table 72. Integra Life Sciences Recent Developments Table 73. AdvanceMedicalSolution Company Information Table 74. AdvanceMedicalSolution Business Overview Table 75. AdvanceMedicalSolution Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. AdvanceMedicalSolution Trauma Hemostasis Device Product Portfolio Table 77. AdvanceMedicalSolution Recent Developments Table 78. CSL Behring Company Information Table 79. CSL Behring Business Overview Table 80. CSL Behring Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. CSL Behring Trauma Hemostasis Device Product Portfolio Table 82. CSL Behring Recent Developments Table 83. Hairun Biotechnology Company Information Table 84. Hairun Biotechnology Business Overview Table 85. Hairun Biotechnology Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Hairun Biotechnology Trauma Hemostasis Device Product Portfolio Table 87. Hairun Biotechnology Recent Developments Table 88. Zimmer Biomet Company Information Table 89. Zimmer Biomet Business Overview Table 90. Zimmer Biomet Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Zimmer Biomet Trauma Hemostasis Device Product Portfolio Table 92. Zimmer Biomet Recent Developments Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Pfizer Trauma Hemostasis Device Product Portfolio Table 97. Pfizer Recent Developments Table 98. Smith & Nephew Company Information Table 99. Smith & Nephew Business Overview Table 100. Smith & Nephew Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Smith & Nephew Trauma Hemostasis Device Product Portfolio Table 102. Smith & Nephew Recent Developments Table 103. Cohera Medical Company Information Table 104. Cohera Medical Business Overview Table 105. Cohera Medical Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Cohera Medical Trauma Hemostasis Device Product Portfolio Table 107. Cohera Medical Recent Developments Table 108. Haohai Biotechnology Company Information Table 109. Haohai Biotechnology Business Overview Table 110. Haohai Biotechnology Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Haohai Biotechnology Trauma Hemostasis Device Product Portfolio Table 112. Haohai Biotechnology Recent Developments Table 113. Sexsays Company Information Table 114. Sexsays Business Overview Table 115. Sexsays Trauma Hemostasis Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Sexsays Trauma Hemostasis Device Product Portfolio Table 117. Sexsays Recent Developments Table 118. Global Trauma Hemostasis Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Trauma Hemostasis Device Sales by Region (2021-2026) & (k units) Table 120. Global Trauma Hemostasis Device Sales Market Share by Region (2021-2026) Table 121. Global Trauma Hemostasis Device Sales by Region (2027-2032) & (k units) Table 122. Global Trauma Hemostasis Device Sales Market Share by Region (2027-2032) Table 123. Global Trauma Hemostasis Device Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Trauma Hemostasis Device Revenue Market Share by Region (2021-2026) Table 125. Global Trauma Hemostasis Device Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Trauma Hemostasis Device Revenue Market Share by Region (2027-2032) Table 127. North America Trauma Hemostasis Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Trauma Hemostasis Device Sales by Country (2021-2026) & (k units) Table 129. North America Trauma Hemostasis Device Sales by Country (2027-2032) & (k units) Table 130. North America Trauma Hemostasis Device Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Trauma Hemostasis Device Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Trauma Hemostasis Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Trauma Hemostasis Device Sales by Country (2021-2026) & (k units) Table 134. Europe Trauma Hemostasis Device Sales by Country (2027-2032) & (k units) Table 135. Europe Trauma Hemostasis Device Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Trauma Hemostasis Device Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Trauma Hemostasis Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Trauma Hemostasis Device Sales by Country (2021-2026) & (k units) Table 139. Asia Pacific Trauma Hemostasis Device Sales by Country (2027-2032) & (k units) Table 140. Asia Pacific Trauma Hemostasis Device Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Trauma Hemostasis Device Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Trauma Hemostasis Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Trauma Hemostasis Device Sales by Country (2021-2026) & (k units) Table 144. South America Trauma Hemostasis Device Sales by Country (2027-2032) & (k units) Table 145. South America Trauma Hemostasis Device Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Trauma Hemostasis Device Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Trauma Hemostasis Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Trauma Hemostasis Device Sales by Country (2021-2026) & (k units) Table 149. Middle East and Africa Trauma Hemostasis Device Sales by Country (2027-2032) & (k units) Table 150. Middle East and Africa Trauma Hemostasis Device Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Trauma Hemostasis Device Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Trauma Hemostasis Device Sales by Type (2021-2026) & (k units) Table 153. Global Trauma Hemostasis Device Sales by Type (2027-2032) & (k units) Table 154. Global Trauma Hemostasis Device Sales Market Share by Type (2021-2026) Table 155. Global Trauma Hemostasis Device Sales Market Share by Type (2027-2032) Table 156. Global Trauma Hemostasis Device Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Trauma Hemostasis Device Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Trauma Hemostasis Device Revenue Market Share by Type (2021-2026) Table 159. Global Trauma Hemostasis Device Revenue Market Share by Type (2027-2032) Table 160. Global Trauma Hemostasis Device Price by Type (2021-2026) & (USD/unit) Table 161. Global Trauma Hemostasis Device Price by Type (2027-2032) & (USD/unit) Table 162. Global Trauma Hemostasis Device Sales by Application (2021-2026) & (k units) Table 163. Global Trauma Hemostasis Device Sales by Application (2027-2032) & (k units) Table 164. Global Trauma Hemostasis Device Sales Market Share by Application (2021-2026) Table 165. Global Trauma Hemostasis Device Sales Market Share by Application (2027-2032) Table 166. Global Trauma Hemostasis Device Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Trauma Hemostasis Device Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Trauma Hemostasis Device Revenue Market Share by Application (2021-2026) Table 169. Global Trauma Hemostasis Device Revenue Market Share by Application (2027-2032) Table 170. Global Trauma Hemostasis Device Price by Application (2021-2026) & (USD/unit) Table 171. Global Trauma Hemostasis Device Price by Application (2027-2032) & (USD/unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Trauma Hemostasis Device Distributors List Table 175. Trauma Hemostasis Device Customers List Table 176. Trauma Hemostasis Device Industry Trends Table 177. Trauma Hemostasis Device Industry Drivers Table 178. Trauma Hemostasis Device Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Trauma Hemostasis Device Product Image Figure 5. Global Trauma Hemostasis Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Trauma Hemostasis Device Market Size (2021-2032) & (US$ Million) Figure 7. Global Trauma Hemostasis Device Sales (2021-2032) & (k units) Figure 8. Global Trauma Hemostasis Device Average Price (USD/unit) & (2021-2032) Figure 9. Hemostatic Devices Product Image Figure 10. Hemostatic Agents Product Image Figure 11. Other Product Image Figure 12. Hospital Product Image Figure 13. Clinic Product Image Figure 14. Other Product Image Figure 15. Global Trauma Hemostasis Device Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Trauma Hemostasis Device, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Trauma Hemostasis Device Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Trauma Hemostasis Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Trauma Hemostasis Device Sales by Region in 2025 Figure 21. Global Trauma Hemostasis Device Revenue by Region in 2025 Figure 22. North America Trauma Hemostasis Device Market Size by Country in 2025 Figure 23. North America Trauma Hemostasis Device Sales Market Share by Country (2021-2032) Figure 24. North America Trauma Hemostasis Device Revenue Market Share by Country (2021-2032) Figure 25. United States Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Trauma Hemostasis Device Market Size by Country in 2025 Figure 29. Europe Trauma Hemostasis Device Sales Market Share by Country (2021-2032) Figure 30. Europe Trauma Hemostasis Device Revenue Market Share by Country (2021-2032) Figure 31. Germany Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Trauma Hemostasis Device Market Size by Country in 2025 Figure 42. Asia Pacific Trauma Hemostasis Device Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Trauma Hemostasis Device Revenue Market Share by Country (2021-2032) Figure 44. China Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Trauma Hemostasis Device Market Size by Country in 2025 Figure 53. South America Trauma Hemostasis Device Sales Market Share by Country (2021-2032) Figure 54. South America Trauma Hemostasis Device Revenue Market Share by Country (2021-2032) Figure 55. Brazil Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Colombia Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Trauma Hemostasis Device Market Size by Country in 2025 Figure 60. Middle East and Africa Trauma Hemostasis Device Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Trauma Hemostasis Device Revenue Market Share by Country (2021-2032) Figure 62. Egypt Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Trauma Hemostasis Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Trauma Hemostasis Device Sales Market Share by Type (2021-2032) Figure 68. Global Trauma Hemostasis Device Revenue Market Share by Type (2021-2032) Figure 69. Global Trauma Hemostasis Device Price (USD/unit) by Type (2021-2032) Figure 70. Global Trauma Hemostasis Device Sales Market Share by Application (2021-2032) Figure 71. Global Trauma Hemostasis Device Revenue Market Share by Application (2021-2032) Figure 72. Global Trauma Hemostasis Device Price (USD/unit) by Application (2021-2032) Figure 73. Trauma Hemostasis Device Value Chain Figure 74. Trauma Hemostasis Device Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Trauma Hemostasis Device Industry Opportunities and Challenges

Scope & coverage.

Types
  • Hemostatic Devices
  • Hemostatic Agents
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Medtronic
  • RevMedx
  • Organon
  • Stryker
  • Delfi Medical Innovations
  • TacMed Solutions
  • J&J
  • Baxter
  • BD
  • BBraun
  • Integra Life Sciences
  • AdvanceMedicalSolution
  • CSL Behring
  • Hairun Biotechnology
  • Zimmer Biomet
  • Pfizer
  • Smith & Nephew
  • Cohera Medical
  • Haohai Biotechnology
  • Sexsays

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Trauma Hemostasis Device Market Size (2021-2032)
  4. 2.2.2 Global Trauma Hemostasis Device Sales (2021-2032)
  5. 2.2.3 Global Trauma Hemostasis Device Market Average Price (2021-2032)
  6. 2.3 Trauma Hemostasis Device by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Hemostatic Devices
  9. 2.3.3 Hemostatic Agents
  10. 2.3.4 Other
  11. 2.4 Trauma Hemostasis Device by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital
  14. 2.4.3 Clinic
  15. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Trauma Hemostasis Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Trauma Hemostasis Device Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Trauma Hemostasis Device Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Trauma Hemostasis Device Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Trauma Hemostasis Device Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Trauma Hemostasis Device, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Trauma Hemostasis Device, Product Type & Application
  8. 3.8 Global Manufacturers of Trauma Hemostasis Device, Established Date
  9. 3.9 Global Trauma Hemostasis Device Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Medtronic
  2. 4.1.1 Medtronic Company Information
  3. 4.1.2 Medtronic Business Overview
  4. 4.1.3 Medtronic Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Medtronic Trauma Hemostasis Device Product Portfolio
  6. 4.1.5 Medtronic Recent Developments
  7. 4.2 RevMedx
  8. 4.2.1 RevMedx Company Information
  9. 4.2.2 RevMedx Business Overview
  10. 4.2.3 RevMedx Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 RevMedx Trauma Hemostasis Device Product Portfolio
  12. 4.2.5 RevMedx Recent Developments
  13. 4.3 Organon
  14. 4.3.1 Organon Company Information
  15. 4.3.2 Organon Business Overview
  16. 4.3.3 Organon Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Organon Trauma Hemostasis Device Product Portfolio
  18. 4.3.5 Organon Recent Developments
  19. 4.4 Stryker
  20. 4.4.1 Stryker Company Information
  21. 4.4.2 Stryker Business Overview
  22. 4.4.3 Stryker Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Stryker Trauma Hemostasis Device Product Portfolio
  24. 4.4.5 Stryker Recent Developments
  25. 4.5 Delfi Medical Innovations
  26. 4.5.1 Delfi Medical Innovations Company Information
  27. 4.5.2 Delfi Medical Innovations Business Overview
  28. 4.5.3 Delfi Medical Innovations Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Delfi Medical Innovations Trauma Hemostasis Device Product Portfolio
  30. 4.5.5 Delfi Medical Innovations Recent Developments
  31. 4.6 TacMed Solutions
  32. 4.6.1 TacMed Solutions Company Information
  33. 4.6.2 TacMed Solutions Business Overview
  34. 4.6.3 TacMed Solutions Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 TacMed Solutions Trauma Hemostasis Device Product Portfolio
  36. 4.6.5 TacMed Solutions Recent Developments
  37. 4.7 J&J
  38. 4.7.1 J&J Company Information
  39. 4.7.2 J&J Business Overview
  40. 4.7.3 J&J Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 J&J Trauma Hemostasis Device Product Portfolio
  42. 4.7.5 J&J Recent Developments
  43. 4.8 Baxter
  44. 4.8.1 Baxter Company Information
  45. 4.8.2 Baxter Business Overview
  46. 4.8.3 Baxter Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Baxter Trauma Hemostasis Device Product Portfolio
  48. 4.8.5 Baxter Recent Developments
  49. 4.9 BD
  50. 4.9.1 BD Company Information
  51. 4.9.2 BD Business Overview
  52. 4.9.3 BD Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 BD Trauma Hemostasis Device Product Portfolio
  54. 4.9.5 BD Recent Developments
  55. 4.10 BBraun
  56. 4.10.1 BBraun Company Information
  57. 4.10.2 BBraun Business Overview
  58. 4.10.3 BBraun Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 BBraun Trauma Hemostasis Device Product Portfolio
  60. 4.10.5 BBraun Recent Developments
  61. 4.11 Integra Life Sciences
  62. 4.11.1 Integra Life Sciences Company Information
  63. 4.11.2 Integra Life Sciences Business Overview
  64. 4.11.3 Integra Life Sciences Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Integra Life Sciences Trauma Hemostasis Device Product Portfolio
  66. 4.11.5 Integra Life Sciences Recent Developments
  67. 4.12 AdvanceMedicalSolution
  68. 4.12.1 AdvanceMedicalSolution Company Information
  69. 4.12.2 AdvanceMedicalSolution Business Overview
  70. 4.12.3 AdvanceMedicalSolution Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 AdvanceMedicalSolution Trauma Hemostasis Device Product Portfolio
  72. 4.12.5 AdvanceMedicalSolution Recent Developments
  73. 4.13 CSL Behring
  74. 4.13.1 CSL Behring Company Information
  75. 4.13.2 CSL Behring Business Overview
  76. 4.13.3 CSL Behring Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 CSL Behring Trauma Hemostasis Device Product Portfolio
  78. 4.13.5 CSL Behring Recent Developments
  79. 4.14 Hairun Biotechnology
  80. 4.14.1 Hairun Biotechnology Company Information
  81. 4.14.2 Hairun Biotechnology Business Overview
  82. 4.14.3 Hairun Biotechnology Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hairun Biotechnology Trauma Hemostasis Device Product Portfolio
  84. 4.14.5 Hairun Biotechnology Recent Developments
  85. 4.15 Zimmer Biomet
  86. 4.15.1 Zimmer Biomet Company Information
  87. 4.15.2 Zimmer Biomet Business Overview
  88. 4.15.3 Zimmer Biomet Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Zimmer Biomet Trauma Hemostasis Device Product Portfolio
  90. 4.15.5 Zimmer Biomet Recent Developments
  91. 4.16 Pfizer
  92. 4.16.1 Pfizer Company Information
  93. 4.16.2 Pfizer Business Overview
  94. 4.16.3 Pfizer Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Pfizer Trauma Hemostasis Device Product Portfolio
  96. 4.16.5 Pfizer Recent Developments
  97. 4.17 Smith & Nephew
  98. 4.17.1 Smith & Nephew Company Information
  99. 4.17.2 Smith & Nephew Business Overview
  100. 4.17.3 Smith & Nephew Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Smith & Nephew Trauma Hemostasis Device Product Portfolio
  102. 4.17.5 Smith & Nephew Recent Developments
  103. 4.18 Cohera Medical
  104. 4.18.1 Cohera Medical Company Information
  105. 4.18.2 Cohera Medical Business Overview
  106. 4.18.3 Cohera Medical Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Cohera Medical Trauma Hemostasis Device Product Portfolio
  108. 4.18.5 Cohera Medical Recent Developments
  109. 4.19 Haohai Biotechnology
  110. 4.19.1 Haohai Biotechnology Company Information
  111. 4.19.2 Haohai Biotechnology Business Overview
  112. 4.19.3 Haohai Biotechnology Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Haohai Biotechnology Trauma Hemostasis Device Product Portfolio
  114. 4.19.5 Haohai Biotechnology Recent Developments
  115. 4.20 Sexsays
  116. 4.20.1 Sexsays Company Information
  117. 4.20.2 Sexsays Business Overview
  118. 4.20.3 Sexsays Trauma Hemostasis Device Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Sexsays Trauma Hemostasis Device Product Portfolio
  120. 4.20.5 Sexsays Recent Developments
5 Global Trauma Hemostasis Device Market Scenario by Region
  1. 5.1 Global Trauma Hemostasis Device Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Trauma Hemostasis Device Sales by Region: 2021-2032
  3. 5.2.1 Global Trauma Hemostasis Device Sales by Region: 2021-2026
  4. 5.2.2 Global Trauma Hemostasis Device Sales by Region: 2027-2032
  5. 5.3 Global Trauma Hemostasis Device Revenue by Region: 2021-2032
  6. 5.3.1 Global Trauma Hemostasis Device Revenue by Region: 2021-2026
  7. 5.3.2 Global Trauma Hemostasis Device Revenue by Region: 2027-2032
  8. 5.4 North America Trauma Hemostasis Device Market Facts & Figures by Country
  9. 5.4.1 North America Trauma Hemostasis Device Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Trauma Hemostasis Device Sales by Country (2021-2032)
  11. 5.4.3 North America Trauma Hemostasis Device Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Trauma Hemostasis Device Market Facts & Figures by Country
  16. 5.5.1 Europe Trauma Hemostasis Device Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Trauma Hemostasis Device Sales by Country (2021-2032)
  18. 5.5.3 Europe Trauma Hemostasis Device Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Trauma Hemostasis Device Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Trauma Hemostasis Device Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Trauma Hemostasis Device Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Trauma Hemostasis Device Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Trauma Hemostasis Device Market Facts & Figures by Country
  41. 5.7.1 South America Trauma Hemostasis Device Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Trauma Hemostasis Device Sales by Country (2021-2032)
  43. 5.7.3 South America Trauma Hemostasis Device Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Trauma Hemostasis Device Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Trauma Hemostasis Device Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Trauma Hemostasis Device Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Trauma Hemostasis Device Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Trauma Hemostasis Device Sales by Type (2021-2032)
  2. 6.1.1 Global Trauma Hemostasis Device Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Trauma Hemostasis Device Sales Market Share by Type (2021-2032)
  4. 6.2 Global Trauma Hemostasis Device Revenue by Type (2021-2032)
  5. 6.2.1 Global Trauma Hemostasis Device Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Trauma Hemostasis Device Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Trauma Hemostasis Device Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Trauma Hemostasis Device Sales by Application (2021-2032)
  2. 7.1.1 Global Trauma Hemostasis Device Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Trauma Hemostasis Device Sales Market Share by Application (2021-2032)
  4. 7.2 Global Trauma Hemostasis Device Revenue by Application (2021-2032)
  5. 7.2.1 Global Trauma Hemostasis Device Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Trauma Hemostasis Device Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Trauma Hemostasis Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Trauma Hemostasis Device Value Chain Analysis
  2. 8.1.1 Trauma Hemostasis Device Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Trauma Hemostasis Device Production Mode & Process
  5. 8.2 Trauma Hemostasis Device Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Trauma Hemostasis Device Distributors
  8. 8.2.3 Trauma Hemostasis Device Customers
9 Global Trauma Hemostasis Device Analyzing Market Dynamics
  1. 9.1 Trauma Hemostasis Device Industry Trends
  2. 9.2 Trauma Hemostasis Device Industry Drivers
  3. 9.3 Trauma Hemostasis Device Industry Opportunities and Challenges
  4. 9.4 Trauma Hemostasis Device Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst